Showing results (21-30 of 224) with videos related to
Sort By:
Pageof 23
Statistical Communications in Infectious Diseases|January 22, 2024
Study design approaches for future active-controlled HIV prevention trialsDeborah Donnell, Sheila Kansiime, David V Glidden, et al.Clinical Trials (London, England)|February 22, 2011
Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in AfricaRhonda White, Modesta Chileshe, Liza Dawson, et al.AIDS and Behavior|March 11, 2011
Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLOREC Andres Bedoya, Mathew J Mimiaga, Geetha Beauchamp, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2016
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure ProphylaxisKenneth K Mugwanya, Christina Wyatt, Connie Celum, et al.Clinical Investigation|February 21, 2012
Experience in international clinical research: the HIV Prevention Trials NetworkNirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, et al.International Journal of Epidemiology|February 7, 2025
Estimating the effect of pre-exposure prophylaxis in Black men who have sex with menAllison Meisner, Fan Xia, Kwun C G Chan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2013
Anal sex role segregation and versatility among men who have sex with men: EXPLORE StudyHong-Van Tieu, Xin Li, Deborah Donnell, et al.AIDS Research and Human Retroviruses|July 1, 2023
Perspectives on Design Approaches for HIV Prevention Efficacy TrialsHolly J Prudden, Roger Tatoud, Holly Janes, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2019
The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 StudyBlythe Adamson, Wafaa El-Sadr, Dobromir Dimitrov, et al.Plos One|April 18, 2015
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventionsPatrick Ndase, Connie Celum, Lara Kidoguchi, et al.Pageof 23